Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1978 Nov;14(5):755-60.
doi: 10.1128/AAC.14.5.755.

Effect of antibiotics on the prevention of experimental Bacteroides fragilis endocarditis

Effect of antibiotics on the prevention of experimental Bacteroides fragilis endocarditis

P L Goldman et al. Antimicrob Agents Chemother. 1978 Nov.

Abstract

The relative efficacy of single doses of antibiotics in modifying the development of Bacteroides fragilis subsp. fragilis endocarditis was studied in an experimental model. Antibiotics were administered 0.5 h before intravenous injection of B. fragilis subsp. fragilis into rabbits prepared by insertion of a polyethylene catheter into the left side of the heart; 48 h later, intracardiac vegetations were excised and cultured anaerobically. B. fragilis was recovered from 92% of untreated animals. After a single dose of procaine penicillin G (250 mg/kg intramuscularly), 80% of the animals remained infected. Chloramphenicol (30 mg/kg), carbenicillin (50 mg/kg), and metronidazole (10 mg/kg) were also ineffective (76, 80, and 75% infected, respectively). Cefamandole (30 mg/kg), cefoxitin (30 mg/kg), and erythromycin (30 mg/kg) were significantly more active (50, 55, and 45% infected, respectively), as were higher doses of carbenicillin. Clindamycin (50 mg/kg) was the most effective regimen (11% infected). At present, the relevance of these results to the therapy of serious B. fragilis infections is not known, but this model may prove useful in the evaluation of the prevention of B. fragilis subsp. fragilis bacteremia.

PubMed Disclaimer

Similar articles

Cited by

References

    1. N Engl J Med. 1954 Mar 4;250(9):372-83; contd - PubMed
    1. J Infect Dis. 1970 Sep;122:Suppl:S9-13 - PubMed
    1. J Lab Clin Med. 1977 Jul;90(1):171-9 - PubMed
    1. Ann Intern Med. 1977 Apr;86(4):456-71 - PubMed
    1. Infect Immun. 1977 Apr;16(1):213-7 - PubMed

Publication types

MeSH terms

LinkOut - more resources